Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells

Nobuhiko Kamada, Kenichi Maeda, Nagamu Inoue, Tadakazu Hisamatsu, Susumu Okamoto, Su Hong Kyong, Takaya Yamada, Noriaki Watanabe, Kanji Tsuchimoto, Haruhiko Ogata, Toshifumi Hibi

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Although the probiotic Escherichia coli strain Nissle 1917 has been used for the treatment of inflammatory bowel diseases, the precise mechanisms of action of this strain remain unclear. In the present study, we estimated the anti-inflammatory effect of E. coli Nissle 1917 on inflammatory responses in vitro to determine he suppressive mechanism of Nissle 1917 on the inflammatory process. To determine the effect of E. coli Nissle 1917, the human colonic epithelial cell line HCT15 was incubated with or without E. coli Nissle 1917 or another nonpathogenic E. coli strain, K-12, and then tumor necrosis factor alpha (TNF-α)-induced interleukin-8 (IL-8) production from HCT15 cells was assessed. Enzyme-linked immunosorbent assays and real-time quantitative PCR showed that Nissle 1917 treatment suppressed TNF-α-induced IL-8 transcription and production. In addition, results from luciferase assays indicated that Nissle 1917 inhibited IL-8 promoter activity On the other hand, these anti-inflammatory effects were not seen with E. coli K-12. In addition, heat-killed Nissle 1917 or its genomic DNA did not have this anti-inflammatory effect. Surprisingly, Nissle 1917 did not affect IL-8 transactivation pathways, such as NF-κB activation, nuclear translocation, and DNA binding, or even activation of other transcriptional factors. Furthermore, it also became evident that Nissle 1917 induced the anti-inflammatory effect without contact to epithelial cells. In conclusion, these data indicate that the non-pathogenic E. coli strain Nissle 1917 expresses a direct anti-inflammatory activity on human epithelial cells via a secreted factor which suppresses TNF-α-induced IL-8 transactivation through mechanisms different from NF-κB inhibition.

Original languageEnglish
Pages (from-to)214-220
Number of pages7
JournalInfection and Immunity
Volume76
Issue number1
DOIs
Publication statusPublished - 2008 Jan

Fingerprint

Signal Transduction
Epithelial Cells
Interleukin-8
Escherichia coli
Anti-Inflammatory Agents
Transcriptional Activation
Tumor Necrosis Factor-alpha
DNA
Probiotics
Luciferases
Inflammatory Bowel Diseases
Human Activities
Real-Time Polymerase Chain Reaction
Hot Temperature
Enzyme-Linked Immunosorbent Assay
Cell Line
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. / Kamada, Nobuhiko; Maeda, Kenichi; Inoue, Nagamu; Hisamatsu, Tadakazu; Okamoto, Susumu; Kyong, Su Hong; Yamada, Takaya; Watanabe, Noriaki; Tsuchimoto, Kanji; Ogata, Haruhiko; Hibi, Toshifumi.

In: Infection and Immunity, Vol. 76, No. 1, 01.2008, p. 214-220.

Research output: Contribution to journalArticle

Kamada, N, Maeda, K, Inoue, N, Hisamatsu, T, Okamoto, S, Kyong, SH, Yamada, T, Watanabe, N, Tsuchimoto, K, Ogata, H & Hibi, T 2008, 'Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells', Infection and Immunity, vol. 76, no. 1, pp. 214-220. https://doi.org/10.1128/IAI.01193-07
Kamada, Nobuhiko ; Maeda, Kenichi ; Inoue, Nagamu ; Hisamatsu, Tadakazu ; Okamoto, Susumu ; Kyong, Su Hong ; Yamada, Takaya ; Watanabe, Noriaki ; Tsuchimoto, Kanji ; Ogata, Haruhiko ; Hibi, Toshifumi. / Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. In: Infection and Immunity. 2008 ; Vol. 76, No. 1. pp. 214-220.
@article{c3c842ee22934db890bf90d5ae7c62cd,
title = "Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells",
abstract = "Although the probiotic Escherichia coli strain Nissle 1917 has been used for the treatment of inflammatory bowel diseases, the precise mechanisms of action of this strain remain unclear. In the present study, we estimated the anti-inflammatory effect of E. coli Nissle 1917 on inflammatory responses in vitro to determine he suppressive mechanism of Nissle 1917 on the inflammatory process. To determine the effect of E. coli Nissle 1917, the human colonic epithelial cell line HCT15 was incubated with or without E. coli Nissle 1917 or another nonpathogenic E. coli strain, K-12, and then tumor necrosis factor alpha (TNF-α)-induced interleukin-8 (IL-8) production from HCT15 cells was assessed. Enzyme-linked immunosorbent assays and real-time quantitative PCR showed that Nissle 1917 treatment suppressed TNF-α-induced IL-8 transcription and production. In addition, results from luciferase assays indicated that Nissle 1917 inhibited IL-8 promoter activity On the other hand, these anti-inflammatory effects were not seen with E. coli K-12. In addition, heat-killed Nissle 1917 or its genomic DNA did not have this anti-inflammatory effect. Surprisingly, Nissle 1917 did not affect IL-8 transactivation pathways, such as NF-κB activation, nuclear translocation, and DNA binding, or even activation of other transcriptional factors. Furthermore, it also became evident that Nissle 1917 induced the anti-inflammatory effect without contact to epithelial cells. In conclusion, these data indicate that the non-pathogenic E. coli strain Nissle 1917 expresses a direct anti-inflammatory activity on human epithelial cells via a secreted factor which suppresses TNF-α-induced IL-8 transactivation through mechanisms different from NF-κB inhibition.",
author = "Nobuhiko Kamada and Kenichi Maeda and Nagamu Inoue and Tadakazu Hisamatsu and Susumu Okamoto and Kyong, {Su Hong} and Takaya Yamada and Noriaki Watanabe and Kanji Tsuchimoto and Haruhiko Ogata and Toshifumi Hibi",
year = "2008",
month = "1",
doi = "10.1128/IAI.01193-07",
language = "English",
volume = "76",
pages = "214--220",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells

AU - Kamada, Nobuhiko

AU - Maeda, Kenichi

AU - Inoue, Nagamu

AU - Hisamatsu, Tadakazu

AU - Okamoto, Susumu

AU - Kyong, Su Hong

AU - Yamada, Takaya

AU - Watanabe, Noriaki

AU - Tsuchimoto, Kanji

AU - Ogata, Haruhiko

AU - Hibi, Toshifumi

PY - 2008/1

Y1 - 2008/1

N2 - Although the probiotic Escherichia coli strain Nissle 1917 has been used for the treatment of inflammatory bowel diseases, the precise mechanisms of action of this strain remain unclear. In the present study, we estimated the anti-inflammatory effect of E. coli Nissle 1917 on inflammatory responses in vitro to determine he suppressive mechanism of Nissle 1917 on the inflammatory process. To determine the effect of E. coli Nissle 1917, the human colonic epithelial cell line HCT15 was incubated with or without E. coli Nissle 1917 or another nonpathogenic E. coli strain, K-12, and then tumor necrosis factor alpha (TNF-α)-induced interleukin-8 (IL-8) production from HCT15 cells was assessed. Enzyme-linked immunosorbent assays and real-time quantitative PCR showed that Nissle 1917 treatment suppressed TNF-α-induced IL-8 transcription and production. In addition, results from luciferase assays indicated that Nissle 1917 inhibited IL-8 promoter activity On the other hand, these anti-inflammatory effects were not seen with E. coli K-12. In addition, heat-killed Nissle 1917 or its genomic DNA did not have this anti-inflammatory effect. Surprisingly, Nissle 1917 did not affect IL-8 transactivation pathways, such as NF-κB activation, nuclear translocation, and DNA binding, or even activation of other transcriptional factors. Furthermore, it also became evident that Nissle 1917 induced the anti-inflammatory effect without contact to epithelial cells. In conclusion, these data indicate that the non-pathogenic E. coli strain Nissle 1917 expresses a direct anti-inflammatory activity on human epithelial cells via a secreted factor which suppresses TNF-α-induced IL-8 transactivation through mechanisms different from NF-κB inhibition.

AB - Although the probiotic Escherichia coli strain Nissle 1917 has been used for the treatment of inflammatory bowel diseases, the precise mechanisms of action of this strain remain unclear. In the present study, we estimated the anti-inflammatory effect of E. coli Nissle 1917 on inflammatory responses in vitro to determine he suppressive mechanism of Nissle 1917 on the inflammatory process. To determine the effect of E. coli Nissle 1917, the human colonic epithelial cell line HCT15 was incubated with or without E. coli Nissle 1917 or another nonpathogenic E. coli strain, K-12, and then tumor necrosis factor alpha (TNF-α)-induced interleukin-8 (IL-8) production from HCT15 cells was assessed. Enzyme-linked immunosorbent assays and real-time quantitative PCR showed that Nissle 1917 treatment suppressed TNF-α-induced IL-8 transcription and production. In addition, results from luciferase assays indicated that Nissle 1917 inhibited IL-8 promoter activity On the other hand, these anti-inflammatory effects were not seen with E. coli K-12. In addition, heat-killed Nissle 1917 or its genomic DNA did not have this anti-inflammatory effect. Surprisingly, Nissle 1917 did not affect IL-8 transactivation pathways, such as NF-κB activation, nuclear translocation, and DNA binding, or even activation of other transcriptional factors. Furthermore, it also became evident that Nissle 1917 induced the anti-inflammatory effect without contact to epithelial cells. In conclusion, these data indicate that the non-pathogenic E. coli strain Nissle 1917 expresses a direct anti-inflammatory activity on human epithelial cells via a secreted factor which suppresses TNF-α-induced IL-8 transactivation through mechanisms different from NF-κB inhibition.

UR - http://www.scopus.com/inward/record.url?scp=37749026070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37749026070&partnerID=8YFLogxK

U2 - 10.1128/IAI.01193-07

DO - 10.1128/IAI.01193-07

M3 - Article

VL - 76

SP - 214

EP - 220

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 1

ER -